Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ASS1 |
| Upstream (Parents) |
|---|
| (<<) BDH1 → ASS1 |
| (<<) AKR7A3 → ASS1 |
| (<<) SORD → ASS1 |
| (<<) FAHD2A → ASS1 |
| Downstream (Children) |
|---|
| ASS1 → SHC3 (>>) |
| ASS1 → HOXD10 (>>) |
| ASS1 → HOXD11 (>>) |
| ASS1 → EYA1 (>>) |
| ASS1 → HOXD4 (>>) |
| ASS1 → SLC6A6 (>>) |
| ASS1 → IFIH1 (>>) |
| ASS1 → NDRG4 (>>) |
| ASS1 → PLA2G1B (>>) |
| ASS1 → MKL1 (>>) |
| ASS1 → RHCE (>>) |
| ASS1 → SPAG11A (>>) |
| ASS1 → KCNMB2 (>>) |
| ASS1 → SLPI (>>) |
| ASS1 → DUSP9 (>>) |
